Drug intelligence / Profile preview

clobetasone butyrate + gentamicin sulfate + miconazole nitrate

Development stage: Unknown
Lead developer: Octave Life Sciences
Modality: Small Molecules
Administration: Topical

Overview

Dermisytic is a topical combination cream containing clobetasone butyrate, gentamicin sulfate, and miconazole nitrate. It is marketed by Octave Life Sciences for the treatment of inflammatory skin conditions complicated by bacterial or fungal infections. Clobetasone butyrate is a corticosteroid that reduces inflammation, redness, and itching. Gentamicin sulfate is an aminoglycoside antibiotic that targets bacterial infections by inhibiting protein synthesis. Miconazole nitrate is an imidazole antifungal that disrupts fungal cell membrane synthesis. Together, these components provide comprehensive relief from skin infections and associated inflammation.

Brand names: DermisyticDermisytic Cream
Other names: clobetasone + gentamicin + miconazoleclobetasone butyrate + gentamicin sulfate + miconazole nitrateclobetasone butyrate, gentamicin sulfate and miconazole nitrate cream

Targets

Bacterial RibosomeGR (Glucocorticoid receptor)CYP51A1 (Sterol 14α-demethylase)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on clobetasone butyrate + gentamicin sulfate + miconazole nitrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on clobetasone butyrate + gentamicin sulfate + miconazole nitrate.